Hawesko Holding AG
- WKN: 604270
- ISIN: DE0006042708
- Land: Deutschland
Nachricht vom 11.08.2021 | 08:00
Hawesko Holding AG: Hawesko Group impresses across all segments in second quarter
DGAP-News: Hawesko Holding AG
/ Key word(s): Half Year Results
E-commerce continued to experience strong demand in the second quarter of 2021, increasing sales by 10 percent. The Retail segment generated an 8 percent increase in sales despite the absence of tastings and events. The B2B segment enjoyed 6 percent growth thanks to strong sales to food retailers. Across all segments, the Hawesko Group improved its second-quarter result compared with the prior-year period: both in absolute terms and as a proportion of sales. Double-digit growth rates were recorded in the B2C segments: in e-commerce EBIT grew by 45 percent, and in retail by 18 percent. The B2B segment impressed with a strong EBIT margin of 5.7 percent.
In the half-year period (January 1 to June 30), consolidated sales of the Hawesko Group rose by 17 percent year on year to € 324.9 million. Group EBIT rose by 138 percent to € 31.1 million. Consolidated net income attributable to Hawesko shareholders more than doubled to € 19.3 million, while earnings per share amounted to € 2.15, compared with € 0.89 in the first half of the previous year.
The current behavior of consumers following the easing of measures to combat the COVID 19 pandemic gives the Board of Management of the Hawesko Group cause for optimism. Based on current knowledge, the rising level of vaccination should mitigate the impact of a fourth wave this fall. The Chairman of the Hawesko Group's Board of Management, Thorsten Hermelink, comments, "In view of the successful first half, we are confident that growth in the end-customer segments will level off, but that overall sales levels will remain at a much higher level than before the pandemic. In addition, we expect the food service industry to recover in the second half of the year, albeit still at a subdued level. Initial trends in the summer months of June and July, with lower growth or sales at the level of the previous year, show that people are now much more mobile again in the summer as a result of the relaxation measures and vaccinations than they were in the previous months or even in the previous year. This will certainly also reduce consumption at home to a certain extent. In this respect, we are proceeding cautiously with our forecast for the second half of 2021 and, if the restrictions remain in place and vaccination rates increase, are calculating with a further recovery in the catering business, but at the same time no longer with further sales growth in the end customer segments."
Against this backdrop, the Board of Management of the Hawesko Group expects overall revenue growth of around 2 to 5 percent for the group in the 2021 financial year. Following € 620 million in sales in 2020, sales are thus expected to range between € 633 and 651 million for 2021 as a whole. Group EBIT is expected to be between € 48 and 55 million (previous year: € 42.2 million), which corresponds to an increase of between 14 and 30 percent compared to the previous year.
# # #
As a leading trading group for high-quality wines, champagnes and spirits, the Hawesko Group achieved sales of € 620 million and EBIT of € 42 million in 2020. The Hawesko Group employs around 1,200 people across the Retail (Jacques' and Wein & Co.), B2B (especially Wein Wolf, Abayan and Grand Cru Select) and e-commerce (especially HAWESKO, Vinos and WirWinzer) segments. The shares in Hawesko Holding AG are listed on the Hanseatic Stock Exchange, Hamburg, and in the Prime Standard segment of the Frankfurt Stock Exchange.
Hawesko Holding AG
hawesko-holding.com Corporate information
Press and Investor Relations contact:
Tel. (+49) 40 3039 2100
|Company:||Hawesko Holding AG|
|Große Elbstraße 145 d|
|Phone:||+49 40 30 39 2100|
|Fax:||+49 40 30 39 2105|
|Listed:||Regulated Market in Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Tradegate Exchange|
|EQS News ID:||1225390|
|End of News||DGAP News Service|
Hawesko Holding AG: Hawesko Group continues gr ...
Hawesko Holding AG: Hawesko Group impresses ac ...
Hawesko Holding AG: Preliminary announcement o ...
Hawesko Holding AG: Annual General Meeting app ...
Hawesko Holding AG: Significant increase in ea ...
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
30. November 12:36 Maydorns Meinung: Moderna, Biontech, Valneva, Lufthansa, Twitter, ...
30. November 12:38 Xiaomi: 50 Prozent Potenzial? Die Wahrheit über die Kursziele nach ...
30. November 13:20 Adler im Sturzflug – noch viele offene Fragen
30. November 13:30 Drei Aktien mit Abstauberlimit
30. November 13:51 CD Projekt: Sprudelnde Gewinne im Jahr nach Cyberpunk? Fehlanzeige!
30. November 2021
Original-Research: clearvise AG (von First Berlin Equity Research GmbH): Buy
30. November 2021